Pain Management in Veterinary Clinical Practice

A special issue of Animals (ISSN 2076-2615). This special issue belongs to the section "Animal System and Management".

Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 13975

Special Issue Editor


E-Mail Website
Guest Editor
Department of Veterinary Medicine (DIMEVET), University of Milan, via dell’Università 6, 26900 Lodi, Italy
Interests: acute and chronic pain; neuropathic pain; central adaptations to chronic pain; endocannabinoids and other lipid signaling molecules

Special Issue Information

Dear Colleagues,

These are very exciting times to promote research with topics covering pain and its treatment: experiencing pain, both acute and chronic, is now extremely common in veterinary patients. While important and successful efforts have been made to improve current pain therapies, important challenges associated with pain assessment and treatment exist and their implementation is required, by revisiting existing and proposing novel approaches. For example, pain treatments are not available for a large number of veterinary patients, and optimal pain management (e.g., multidisciplinary) is relatively rare. Changing the approach to pain assessment and treatment is required in order to improve pain care in terms of efficiency, effectiveness, and safety.

In this Special Issue, we invite original research and reviews in the field of both acute and chronic pain, in order to increase the quality of life of animals affected by different painful conditions.

Prof. Giuliano Ravasio
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Animals is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • acute pain
  • analgesia
  • chronic pain
  • locoregional anesthesia
  • pain management
  • peri-anesthetic analgesia

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 242 KiB  
Article
Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis
by Federica Alessandra Brioschi, Federica Di Cesare, Daniela Gioeni, Vanessa Rabbogliatti, Francesco Ferrari, Elisa Silvia D’Urso, Martina Amari and Giuliano Ravasio
Animals 2020, 10(9), 1505; https://doi.org/10.3390/ani10091505 - 26 Aug 2020
Cited by 55 | Viewed by 13077
Abstract
The aim of this study was to evaluate the efficacy of oral transmucosal (OTM) cannabidiol (CBD), in addition to a multimodal pharmacological treatment for chronic osteoarthritis-related pain in dogs. Twenty-one dogs were randomly divided into two groups: in group CBD (n = [...] Read more.
The aim of this study was to evaluate the efficacy of oral transmucosal (OTM) cannabidiol (CBD), in addition to a multimodal pharmacological treatment for chronic osteoarthritis-related pain in dogs. Twenty-one dogs were randomly divided into two groups: in group CBD (n = 9), OTM CBD (2 mg kg−1 every 12 h) was included in the therapeutic protocol (anti-inflammatory drug, gabapentin, amitriptyline), while in group C (n = 12), CBD was not administered. Dogs were evaluated by owners based on the Canine Brief Pain Inventory scoring system before treatment initiation (T0), and one (T1), two (T2), four (T3) and twelve (T4) weeks thereafter. Pain Severity Score was significantly lower in CBD than in C group at T1 (p = 0.0002), T2 (p = 0.0043) and T3 (p = 0.016). Pain Interference Score was significantly lower in CBD than in C group at T1 (p = 0.0002), T2 (p = 0.0007) and T4 (p = 0.004). Quality of Life Index was significantly higher in CBD group at T1 (p = 0.003). The addition of OTM CBD showed promising results. Further pharmacokinetics and long-term studies in larger populations are needed to encourage its inclusion into a multimodal pharmacological approach for canine osteoarthritis-related pain. Full article
(This article belongs to the Special Issue Pain Management in Veterinary Clinical Practice)
Back to TopTop